Datar Cancer Genetics has set itself the task of offering solutions, especially for advanced stages (e.g. breast cancer, prostate cancer) or for solid tumours that are difficult to treat. At the same time, we recognise that early detection of cancer is much more likely to lead to successful treatment, for example in colon cancer or ovarian carcinoma. There is a wealth of information available in the blood, the analysis of which, combined with advanced artificial intelligence, helps to optimise therapy. Based on clinical studies in recent years, Datar Cancer Genetics has been able to develop evidence-based testing procedures in both therapy management and cancer screening. In total, more than 40,000 patients have been enrolled in our studies to date, making a significant contribution to cancer diagnosis and therapy.
Trucheck™ is a new blood paradigm for the detection of multiple cancers.
The following options are available:
– Trucheck™ intelli (up to 70 types of solid tumours)
– Trucheck™ FemmeSafe (breast, ovary, uterus, cervix)
Trublood is a minimally invasive diagnostic test that can clearly identify cancer in symptomatic patients.
Trublood provides diagnostic information similar to that provided by tissue biopsy when it is not conclusive or not possible.
Based on the test results, therapy can be tailored.
exacta is a comprehensive analysis of the molecular-genetic characteristics of solid tumours, based on the results of several clinical studies. Especially for rare solid tumours for which no guidelines are available, in advanced disease or for difficult-to-treat tumours, Exacta is an advantage. Exacta analyses millions of data at the molecular level to identify all relevant targets for individualised therapy.
Celldx is a tissue-based comprehensive molecular profiling of solid tumours to tailor treatment options.
Results are usually available within eight working days and, in addition to genetic analysis, provide information on the usefulness of immune checkpoint inhibitors.
Cancertrack is a blood-based assay that detects cancer-related biomarkers with extremely high accuracy, specificity and reliability.
Cancertrack enables continuous cancer monitoring to detect recurrences or changes in tumour characteristics at an early stage.
Cancer is an extremely heterogeneous disease.
Chemotherapies do not work the same for every patient.
Chemo-scale uses a blood sample to study the effectiveness of chemotherapies in an individual patient.
The likelihood of successful therapy can be significantly increased in certain cases, while treatment failure can be largely prevented.
“I have suffered from chronic joint pain, especially in my knees, for several years. Traditional treatments such as physical therapy, painkillers and even corticosteroid injections have only provided temporary relief. Desperate for a more permanent solution, I started researching alternative treatments and came across mesenchymal stem/stromal cell (MSC) therapy. After consulting my doctor and doing extensive research, I decided to give it a try.
The treatment process was simple and professionally managed. The first consultation included a thorough assessment of my condition and detailed information on how MSC therapy works. The procedure itself was minimally invasive and surprisingly quick.
What surprised me most was the gradual but noticeable improvement in my condition. Within a few weeks I felt significant pain relief and increased mobility. Tasks that had become difficult or impossible, such as walking up stairs, lifting objects and even walking for long periods of time, became much easier. The stiffness and constant pain that had plagued me for years were greatly reduced. Three months after treatment, I can say with certainty that the improvement has been remarkable. The quality of my life has improved significantly.
I highly recommend MSC therapy to anyone who suffers from chronic joint pain. It has been a game changer for me, providing long term relief where other treatments have failed. The professionalism and care of the medical team (Crystal?) combined with the innovation of the treatment made for an exceptional experience. If you are considering this option, I would recommend that you consult with a qualified healthcare professional to determine whether MSC therapy could be the solution you have been looking for. “
“My name is Milena and I am happy to share my experience of stem cell therapy for Heberden’s and Bouchard’s osteoarthritis of the toes. For years I have been struggling with unbearable pain and swelling in most of my fingers, but especially in three of them, which has affected my daily life.
After extensive research and consultations, I was advised by rheumatologists that medicine has no cure for small joint diseases and that I can only relieve them with painkillers. So I decided to try stem cell therapy. In the procedure, stem cells were injected into each joint of the fingers of both hands. The procedure went smoothly and professionally, but also with not too much pain.
The results were great. I noticed a significant reduction in swelling and pain in a short time. Gradually, the mobility of my fingers improved to some extent, but most importantly, I no longer woke up at night in pain, I no longer had to take painkillers and I was able to do everyday tasks again, including gardening.
Stem cell therapy has made my life easier and, above all, it has eliminated the need to take painkillers, which in the long run also have side effects. I am immensely grateful for the advances in medical science that have made this possible and for the skilled professionals who have guided the treatment. If you suffer from osteoarthritis, I recommend that you opt for stem cell therapy.”